Renal cell carcinoma co-existent with other renal disease: clinico-pathological features in pre-dialysis patients and those receiving dialysis or renal transplantation
- PMID: 15316098
- DOI: 10.1093/ndt/gfh458
Renal cell carcinoma co-existent with other renal disease: clinico-pathological features in pre-dialysis patients and those receiving dialysis or renal transplantation
Abstract
Background: Patients on chronic dialysis are prone to developing acquired cystic kidney disease (ACKD), which may lead to the development of renal cell carcinoma (RCC). The risk factors for the development of RCC so far have not been determined in pre-dialysis patients with co-existent renal disease. The aim of this study was to evaluate the clinico-pathological features of RCC in pre-dialysis patients with associated renal diseases or in those undergoing chronic dialysis and renal transplantation.
Methods: We studied 32 kidneys from 31 patients with RCC and associated renal diseases. Of those, 18 kidneys were from 17 patients not on renal replacement therapy (RRT) when diagnosed with RCC; 14 patients received dialysis or dialysis followed by renal transplantation. Several clinico-pathological features were analysed and compared between the two groups.
Results: Overall, there was a preponderance of males (75%); nephrosclerosis was the predominant co-existent disease (31%). The median intervals from renal disease to RCC in the dialysis and transplanted groups were significantly longer than in the pre-dialysis group (15.8+/-1.1 vs 2.4+/-0.7 years, P<0.0001). In contrast to pre-dialysis RCC, the dialysis and transplant RCC groups had greater frequency of ACKD (100 vs 28%, P<0.0001), papillary type RCC (43 vs 11%, P<0.05) and multifocal tumours (43 vs 5%, P<0.05). At the end of the study, 71% of dialysis and transplanted patients and 72% of pre-dialysis patients were alive.
Conclusions: ACKD develops in dialysis patients, as it does in those with renal disease prior to RRT. The duration of renal disease, rather than the dialysis procedure itself, appears to be the main determinant of ACKD and RCC. The RCC occurring in patients with ACKD and prolonged RRT is more frequently of the papillary type and multifocal than the RCC occurring in patients with no or few acquired cysts and a short history of renal disease. Long-term outcomes did not differ between the two groups.
Similar articles
-
Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?BJU Int. 2012 Dec;110(11 Pt B):E570-3. doi: 10.1111/j.1464-410X.2012.11273.x. Epub 2012 Jun 22. BJU Int. 2012. PMID: 22726451
-
Renal cell carcinoma in transplant recipients with acquired cystic kidney disease.Clin J Am Soc Nephrol. 2007 Jul;2(4):750-6. doi: 10.2215/CJN.03661106. Epub 2007 Apr 25. Clin J Am Soc Nephrol. 2007. PMID: 17699492
-
Features and outcomes of renal cell carcinoma of native kidneys in renal transplant recipients.BJU Int. 2010 May;105(9):1260-5. doi: 10.1111/j.1464-410X.2009.08941.x. Epub 2009 Oct 10. BJU Int. 2010. PMID: 19818071
-
Acquired cystic kidney disease.Radiol Clin North Am. 1996 Sep;34(5):947-64. Radiol Clin North Am. 1996. PMID: 8784391 Review.
-
Renal neoplasia and acquired cystic kidney disease in patients receiving long-term dialysis.Arch Pathol Lab Med. 1986 Jul;110(7):592-601. Arch Pathol Lab Med. 1986. PMID: 3521533 Review.
Cited by
-
Severe Vaginal Bleeding in a Case of Renal Cell Carcinoma.Case Rep Obstet Gynecol. 2019 May 27;2019:2174051. doi: 10.1155/2019/2174051. eCollection 2019. Case Rep Obstet Gynecol. 2019. PMID: 31360564 Free PMC article.
-
Retrospective assessment of the frequency of cancer in the population of kidney transplant recipients - the experience of two transplant centers.Front Oncol. 2025 Jul 14;15:1497691. doi: 10.3389/fonc.2025.1497691. eCollection 2025. Front Oncol. 2025. PMID: 40727470 Free PMC article.
-
Contemporary epidemiology of renal cell cancer.Cancer J. 2008 Sep-Oct;14(5):288-301. doi: 10.1097/PPO.0b013e3181867628. Cancer J. 2008. PMID: 18836333 Free PMC article.
-
Novel sunitinib strategy in metastatic renal cell carcinoma on hemodialysis: intermittent dose of sunitinib after hemodialysis.Cancer Res Treat. 2010 Sep;42(3):180-4. doi: 10.4143/crt.2010.42.3.180. Epub 2010 Sep 30. Cancer Res Treat. 2010. PMID: 20948925 Free PMC article.
-
Histological characterisation of small renal masses and incidence of silent renal masses.Adv Urol. 2008;2008:758073. doi: 10.1155/2008/758073. Epub 2008 Nov 4. Adv Urol. 2008. PMID: 19009035 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical